Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioLineRx Operating Expenses 2012-2025 | BLRX

BioLineRx operating expenses from 2012 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  
BioLineRx Annual Operating Expenses
(Millions of US $)
2024 $49
2023 $54
2022 $29
2021 $25
2020 $23
2019 $28
2018 $26
2017 $25
2016 $17
2015 $16
2014 $17
2013 $17
2012 $22
2011 $15
BioLineRx Quarterly Operating Expenses
(Millions of US $)
2025-03-31 $3
2024-12-31 $16
2024-09-30 $10
2024-06-30 $11
2024-03-31 $12
2023-12-31 $23
2023-09-30 $12
2023-06-30 $10
2023-03-31 $9
2022-12-31 $8
2022-09-30 $7
2022-06-30 $8
2022-03-31 $6
2021-12-31 $7
2021-09-30 $6
2021-06-30 $7
2021-03-31 $5
2020-12-31 $6
2020-09-30 $5
2020-06-30 $6
2020-03-31 $7
2019-12-31 $9
2019-09-30 $7
2019-06-30 $6
2019-03-31 $6
2018-12-31 $7
2018-09-30 $6
2018-06-30 $6
2018-03-31 $7
2017-12-31 $8
2017-09-30 $7
2017-06-30 $5
2017-03-31 $5
2016-12-31 $4
2016-09-30 $4
2016-06-30 $4
2016-03-31 $4
2015-12-31 $4
2015-09-30 $4
2015-06-30 $4
2015-03-31 $4
2014-12-31 $4
2014-09-30 $4
2014-06-30 $4
2014-03-31 $4
2013-12-31 $3
2013-09-30 $3
2013-06-30 $5
2013-03-31 $7
2012-12-31 $7
2012-09-30 $5
2012-06-30 $5
2012-03-31 $5
2011-12-31
2011-09-30 $5
2011-06-30 $4
2011-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.017B $0.029B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $69.309B 26.66
Zoetis (ZTS) United States $67.559B 24.51
Takeda Pharmaceutical (TAK) Japan $46.997B 9.59
Daiichi Sankyo, - (DSNKY) Japan $46.127B 23.64
BeOne Medicines - (ONC) Switzerland $33.703B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.121B 0.00
Summit Therapeutics (SMMT) United States $19.960B 0.00
Merck (MKKGY) Germany $16.834B 10.94
Shionogi (SGIOY) Japan $15.517B 15.55
United Therapeutics (UTHR) United States $13.970B 12.09
Neurocrine Biosciences (NBIX) United States $13.054B 38.94
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Madrigal Pharmaceuticals (MDGL) United States $8.292B 0.00
Corcept Therapeutics (CORT) United States $7.671B 64.43
Grifols, S.A (GRFS) Spain $7.316B 0.00
Ionis Pharmaceuticals (IONS) United States $6.870B 0.00
Stevanato Group S.p.A (STVN) Italy $6.772B 39.93
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.312B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.946B 14.03
NewAmsterdam Pharma (NAMS) Netherlands $2.892B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.834B 0.00
Hypermarcas (HYPMY) Brazil $2.665B 20.04
Catalyst Pharmaceuticals (CPRX) United States $2.471B 8.27
Centessa Pharmaceuticals (CNTA) United Kingdom $2.298B 0.00
Ocular Therapeutix (OCUL) United States $2.175B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.791B 0.00
Dyne Therapeutics (DYN) United States $1.741B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.581B 23.55
ARS Pharmaceuticals (SPRY) United States $1.554B 0.00
Guardian Pharmacy Services (GRDN) United States $1.490B 0.00
Ardelyx (ARDX) United States $1.386B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Harrow (HROW) United States $1.351B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.332B 0.00
Collegium Pharmaceutical (COLL) United States $1.193B 6.52
Xeris Biopharma Holdings (XERS) United States $1.176B 0.00
Cronos Group (CRON) Canada $1.006B 0.00
Enliven Therapeutics (ELVN) United States $0.981B 0.00
Akebia Therapeutics (AKBA) United States $0.875B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.740B 0.00
ProKidney (PROK) United States $0.694B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.656B 6.76
KalVista Pharmaceuticals (KALV) United States $0.629B 0.00
Siga Technologies (SIGA) United States $0.629B 7.77
Organogenesis (ORGO) United States $0.623B 0.00
Theravance Biopharma (TBPH) United States $0.621B 51.75
Bioventus (BVS) United States $0.619B 15.06
Relay Therapeutics (RLAY) United States $0.590B 0.00
Oruka Therapeutics (ORKA) United States $0.574B 0.00
USANA Health Sciences (USNA) United States $0.572B 11.72
Tourmaline Bio (TRML) United States $0.571B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Xencor (XNCR) United States $0.551B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.540B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Savara (SVRA) United States $0.467B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Esperion Therapeutics (ESPR) United States $0.385B 0.00
Nanobiotix S.A (NBTX) France $0.376B 0.00
Altimmune (ALT) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.322B 0.00
Nektar Therapeutics (NKTR) United States $0.319B 0.00
4D Molecular Therapeutics (FDMT) United States $0.312B 0.00
Larimar Therapeutics (LRMR) United States $0.308B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 19.26
AleAnna (ANNA) United States $0.287B 0.00
OmniAb (OABI) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.232B 0.00
Heron Therapeutics (HRTX) United States $0.215B 0.00
Lyell Immunopharma (LYEL) United States $0.208B 0.00
MediWound (MDWD) Israel $0.203B 0.00
China SXT Pharmaceuticals (SXTC) China $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Korro Bio (KRRO) United States $0.178B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.176B 27.25
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.169B 0.00
MEI Pharma (MEIP) United States $0.166B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.118B 0.00
Liminatus Pharma (LIMN) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Dominari Holdings (DOMH) United States $0.101B 0.00
Champions Oncology (CSBR) United States $0.094B 21.38
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
Achieve Life Sciences (ACHV) Canada $0.088B 0.00
Surrozen (SRZN) United States $0.086B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Nutriband (NTRB) United States $0.074B 0.00
Metagenomi (MGX) United States $0.073B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.062B 0.00
DURECT (DRRX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 26.64
NRx Pharmaceuticals (NRXP) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
FibroGen (FGEN) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Scienture Holdings (SCNX) United States $0.036B 0.00
Plus Therapeutics (PSTV) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.033B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
Lipocine (LPCN) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.90
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00